Avatrombopag (2) (Doptelet®) – Thrombocytopenia in chronic liver disease

1. Characteristics

Start date 01.04.2021
Resolution 16.09.2021
INN Avatrombopag
Brand name Doptelet®
Company Swedish Orphan Biovitrum GmbH
G-BA procedure ID 2021-04-01-D-648
ATC code B02BX08
ICD-10 codes D69.57, D69.58, D69.59Other secondary thrombocytopenia
Therapeutic area Hematopoietic diseases
Reason for procedure New indication
Specialties Bundling

Indication (German)

Doptelet is indicated for the treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.

Subgroup Indication Comparator
Erwachsene mit einer schweren Thrombozytopenie aufgrund einer chronischen Lebererkrankung, bei denen ein invasiver Eingriff geplant ist Beobachtendes Abwarten

9. Associated procedures

Resolution INN Brand name Indication Additional benefit
Avatrombopag Doptelet® Immune thrombocytopenia (ITP)
Avatrombopag (2) Doptelet® Thrombocytopenia in chronic liver disease


<< List of all resolutions